Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Share-based Compensation: 2009-2025

Historic Share-based Compensation for Innoviva (INVA) over the last 17 years, with Sep 2025 value amounting to $2.4 million.

  • Innoviva's Share-based Compensation rose 48.47% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year increase of 39.22%. This contributed to the annual value of $6.4 million for FY2024, which is 9.20% up from last year.
  • Per Innoviva's latest filing, its Share-based Compensation stood at $2.4 million for Q3 2025, which was down 1.73% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Innoviva's Share-based Compensation registered a high of $3.7 million during Q3 2022, and its lowest value of $451,000 during Q1 2021.
  • For the 3-year period, Innoviva's Share-based Compensation averaged around $1.8 million, with its median value being $1.6 million (2024).
  • Its Share-based Compensation has fluctuated over the past 5 years, first surged by 585.79% in 2022, then plummeted by 61.21% in 2023.
  • Innoviva's Share-based Compensation (Quarterly) stood at $542,000 in 2021, then spiked by 585.79% to $3.7 million in 2022, then plummeted by 61.21% to $1.4 million in 2023, then grew by 11.17% to $1.6 million in 2024, then soared by 48.47% to $2.4 million in 2025.
  • Its last three reported values are $2.4 million in Q3 2025, $2.4 million for Q2 2025, and $2.1 million during Q1 2025.